Article detail · 2024
Tocilizumab as a first line biologic agent in rheumatoid arthritis patients with inadequate response to disease-modifying anti-rheumatic drugs: real life experience from the TReasure Registry
YÖKSİS
SJR Q2
- Year
- 2024
Data source split
- YÖKSİS YÖKSİS article record
- YÖKSİS venue Clinical and Experimental Rheumatology
- Catalog match (ISSN) Clinical and Experimental Rheumatology
Abstract
Abstract not compiled yet; it will appear after the DergiPark / OpenAlex queue runs.